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Abstract
Since its inception, colonoscopy has evolved to become the cornerstone for colorectal
imaging. The increasing indications for endoscopic evaluation and potential therapeutic
intervention parallels technological advances and the expanding diagnostic and thera‐
peutic capabilities of colonoscopy. The diagnostic and therapeutic yield of colonoscopy is
highly user dependent. Thus, it is essential for the clinical endoscopist to perform a thor‐
ough endoscopic evaluation and be cognizant of normal and pathologic findings. This re‐
view details normal and pathologic endoscopic findings in a variety of disease states that
are often encountered by the clinical endoscopist including colon polyps, inflammatory
bowel disease, and infectious and non-infectious colitides. In addition, we review the di‐
agnostic and therapeutic role of colonoscopy in the evaluation of an acute lower gastroin‐
testinal bleed.
Keywords: Polyp, pseudopolyp, hyperplastic polyp, adenoma, tubular adenoma, tubulo‐
villous adenoma, sessile adenoma, sessile serrated adenoma, colitis, diverticulosis, hem‐
orrhoids, anal fissure
1. Introduction
The advent of retrograde colonoscopy in June 1969 revolutionized the field of gastroenterology
[1]. It has since evolved to become the gold standard for colorectal imaging [2, 3].
As technology continues to advance, so too does the diagnostic utility and therapeutic
capabilities of colonoscopy. Thus, it becomes imperative for the clinical endoscopist to perform
a thorough colonoscopic evaluation and be cognizant of normal and pathologic findings as
indications for colonoscopy expand. Here, we detail normal and pathologic endoscopic
findings in a variety of disease states that are often encountered by the clinical endoscopist
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including colon polyps, inflammatory bowel disease (IBD), and infectious and non-infectious
colitides. In addition, we review the diagnostic and therapeutic role of colonoscopy in the
evaluation of an acute lower gastrointestinal bleed.
2. Polyps and potential progression to colorectal cancer
Colorectal cancer is the third most common cancer among men and women, and the third
leading cause of cancer-related death in the United States [4]. It is estimated that in 2014, 71,830
men and 65,000 women were diagnosed with colorectal cancer with approximately 50,000
mortalities (26,270 men and 24,040 women) as a result of the disease. Globally, colorectal cancer
is the fourth leading cause of cancer-related death accounting for approximately 700,000 deaths
in 2012 [5]. The vast majority of colorectal cancers stem from benign polyps arising from the
mucosal layer. Winawer et al. were among the first to demonstrate that colorectal adenomas
have the potential to progress to colorectal adenocarcinoma, thus stressing the importance of
colonoscopic polypectomy in colorectal cancer prevention [6]. Subsequent long term data has
validated the importance of colonoscopy and colonoscopic polypectomy in the prevention of
colorectal cancer-related deaths [7]. To date, colonoscopy remains the cornerstone in colorectal
cancer prevention. Unfortunately, the “miss rate” of colonoscopy for colorectal cancer and
adenomas larger than 1 cm has been reported to be as high as 6% [8] and 17% [9, 10], respec‐
tively.
Adenomas and hamartomatous polyps, later discussed in depth, are polyps that carry
malignant potential. They are indolent in nature, typically growing slowly over the span of a
decade or more. There is a direct correlation between the size of the adenoma and its risk of
developing future advanced adenomas or carcinoma with studies demonstrating this risk to
be as high as 7.7% [11], 15.9% [11], and 19.3% [12], for adenomas <5mm, 5–20mm, and >20mm,
respectively.
Chromosomal instability and common point mutations occurring in colorectal cancer-related
tumor suppressor genes (e.g., APC, P53) or tumor promoter genes (e.g., K-Ras) architect the
progression from benign polyps to colorectal cancer. Figure 1 depicts key point mutations and
its impact on morphologic changes of a benign polyp to colorectal cancer. There is, however,
considerable genetic and epigenetic heterogeneity resulting in different pathways to tumori‐
genesis [13]. Luo et al. sought to evaluate the effect of these alterations on the progression to
colorectal cancer by conducting genome-wide array-based studies and comprehensive data
analysis of aberrantly methylated loci in normal colon tissue (n=41), colon adenomas (n=42),
and colorectal cancer (n=64) [14]. They identified three classes of cancers and two classes of
adenomas, high-frequency methylation and low-frequency methylation based on their DNA
methylation patterns. Mutant K-Ras was found in a subset of high-frequency methylated
adenomas. In addition, they found the methylation signatures of high-frequency methylation
adenomas to be similar to those of cancer with low or intermediate levels of methylation, and
low-frequency methylation adenomas to have methylation signatures similar to that of normal
colon tissue. These findings demonstrated genome-wide alterations in DNA methylation to
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occur during the early stages of progression of adenomas to colorectal cancer, and the presence
of heterogeneity in tumorigenesis, even at the adenoma step of the process.
Figure 1. Key point mutations and its impact on morphologic changes of a benign polyp to colorectal cancer.
3. Polyps and pseudopolyps
In 2003, the Paris Endoscopic Classification arose to describe polyp morphology [15], which
can potentially guide the endoscopist toward its malignancy potential [16–18]. Figure 2
provides a schematic overview of the Paris Endoscopic Classification and Figure 3 provides
an endoscopic view of differing polyp morphology under traditional white-light colonoscopy.
A recent study by van Doom et al. evaluated the interobserver agreement for the Paris
Endoscopic Classification among seven expert endoscopists [19]. The seven expert endoscop‐
ists assessed 85 endoscopic video clips depicting polyps. Afterwards, they underwent a digital
training module and then assessed the same 85 polyps again. A calculated Fleiss kappa of 0.42
and a mean pairwise agreement of 67% suggested moderate interobserver agreement among
the seven experts. In addition, the proportion of lesions labeled as “flat” lesions ranged
between 13–40% (p<0.001). The interobserver agreement did not change significantly after the
digital training module, which led the investigators to conclude there to be only moderate
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interobserver agreement among experts for this classification system and that use of this
classification system in daily practice is questionable and unsuitable for comparative endo‐
scopist research. Thus, the need for a simplified classification system is necessary to better aid
the clinical endoscopist.
Figure 2. The Paris Classification based on polyp appearance.
Figure 3. Endoscopic views of differing polyp morphology under traditional white-light colonoscopy: (A) Pedunculat‐
ed polyp, (B) Sessile polyp, (C) Flat polyp.
In addition to traditional white-light colonoscopy, several studies have demonstrated the
utility of narrow-band-imaging (NBI) to be useful in adenoma detection [20–23]. Under NBI,
Screening for Colorectal Cancer with Colonoscopy82
adenomas appear to have thicker and higher volumes of microvasculature compared to normal
mucosa and hyperplastic polyps, resulting in distinct pit patterns that may increase diagnostic
yield [23]. This section will review the morphology and histology, malignant potential, and
provide endoscopic and pathologic depictions of different polyp subtypes.
3.1. Adenomas
Adenomatous polyps by definition are dysplastic and thus carry malignant potential. They
can further be characterized as being an advanced adenoma, synchronous adenoma, or
metachronous adenoma. An advanced adenoma is defined as an adenoma with high-grade
dysplasia, an adenoma with a size >10 mm, an adenoma with significant villous components
(>25%), or an adenoma with evidence of invasive carcinoma [24]. Synchronous adenomas are
polyps that are diagnosed at the same time as an index colorectal cancer and metachranous
adenomas are ones diagnosed at least six months before or after the diagnosis of an index
colorectal cancer [25]. The diagnosis of synchronous and metachranous adenomas are of
utmost importance as it can potentially identify individuals at risk for hereditary conditions,
thus impacting therapeutic intervention and screening intervals for relatives [26].
3.1.1. Tubular, villous, and tubulovillous adenomas
Adenomas are characterized as tubular, villous, or tubulovillous (a mixture of the two) based
on their glandular architecture. Tubular adenomas, which account for the vast majority of
colon adenomas, are characterized by a network of branching adenomatous epithelium and a
tubular component of >75% [16]. Figure 4 depicts a histologic representation of a tubular
adenoma in the background of normal colon tissue. Villous adenomas, which account for up
to 15% of adenomas, are characterized by long glands that extend straight down to the center
of the polyp from its surface with a villous component of >75% [16]. Figure 5 depicts a histologic
representation of a villous adenoma in the background of normal colon tissue. Lastly, tubu‐
lovillous adenomas, which account for up to 15% of adenomas, are a mixture of the two
previous adenomas with a villous component of anywhere from 26–75%. Figure 6 depicts a
histologic representation of a tubulovillous adenoma in the background of normal colon tissue.
The CpG island methylator phenotype (CIMP) pathway is composed of methylated promoter
regions of multiple putative tumor suppressor genes occurring in colorectal cancer and also
in adenomatous polyps [27]. Kakar et al. examined villous/tubulovillous adenomas (n=32) and
tubular adenomas (n=30) for BRAF/K-Ras mutations and CIMP-status (characterized by
methylation of three or more loci at hMLH1, p16, HIC1, RASSF2, MGMT, MINT1, and
MINT31) [28]. They found 44% of villous/tubulovillous to be CIMP-positive compared with
27% of tubular adenomas (p=0.08). In addition, villous/tubulovillous adenomas demonstrated
significantly higher methylation rates at MGMT (87% vs. 37%; p<0.01) and RASSF2 (94% vs.
70%; p=0.02) when compared to tubular adenomas. Lastly, CIMP-positive adenomas correlat‐
ed with increased size, right-sided location, and increased villous component in villous/
tubulovillous adenomas. This led the authors to conclude that CIMP status is indicative of size,
location, and malignant potential, and that methylation of MGMT and RASSF2 increases as
adenomas progress from tubular adenomas to villous/tubulovillous adenomas.
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3.1.2. Sessile serrated adenomas, traditional serrated adenomas, and hyperplastic polyps
Serrated lesions account for approximately 30% of colorectal cancers, arising via the serrated
neoplasia pathway characterized by widespread DNA methylation and BRAF mutations [29].
They are classified histologically as sessile serrated adenomas/polyps (SSA/Ps), traditional
serrated adenomas (TSAs), or hyperplastic polyps, with only SSA/Ps and TSAs carrying
malignant potential [30]. SSA/Ps typically lack classic dysplasia, however, those that demon‐
strate foci of classic histologic dysplasia and molecular profiles exhibiting methylation of DNA
repair genes (e.g., MLH-1) are thought to be precursor lesions to sporadic unstable microsa‐
tellite (MSI-H) cancers. SSA/Ps also exhibit activation of the BRAF oncogene, a feature seen in
many sporadic MSI-H cancers [31]. Figure 7 depicts two potential molecular pathways of
serrated neoplasia.
SSA/Ps tend to be more prominent in the proximal colon [32] as compared with TSAs [33] and
hyperplastic polyps [34], which tend to be more prominent in the rectosigmoid. Thus, expert
recommendations are to completely remove all serrated lesions proximal to the sigmoid colon
and all serrated lesions in the rectosigmoid >5mm [30]. They may be more difficult to detect
Figure 4. Histologic representation of tubular adenoma in the background of normal colon tissue.
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than conventional adenomatous polyps, in particular SSA/Ps, since they are more likely to be
flat lesions, and so recent studies have advocated for a longer withdrawal time to increase
serrated lesion detection rates [35, 36].
Serrated lesions have a distinct endoscopic appearance albeit often very subtle. A retrospective
analysis of high-resolution endoscopic video clips by Tadepalli et al. analyzed the gross
morphologic characteristics of 158 SSPs [37]. They found the most prevalent visual descriptors
to be the presence of a mucous cap (which may be yellow or green in white light and red under
NBI) (63.9%), rim of debris or bubbles (51.9%), alteration of the contour of a fold (37.3%), and
interruption of underlying vascular pattern (32%). Figure 8 depicts an SSP under traditional
white-light colonoscopy with a superficial mucous cap, its appearance under NBI, and a
histologic representation.
Figure 5. Histologic representation of villous adenoma in the background of normal colon tissue.
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Hyperplastic polyps are the most common non-neoplastic polyps in the colon; however, they
are oftentimes grossly indistinguishable from adenomatous polyps. Histologically, hyper‐
plastic polyps resemble normal colonic tissue with the exception of proliferation in the basal
portion of the crypt and a characteristic “saw tooth” pattern along the crypt axis [38]. The
relationship between diminutive hyperplastic polyps in the left colon and proximal neoplasia
has long been a topic of debate with studies producing mixed results [39–42]. Hyperplastic
polyps found proximal to the left colon, however, have consistently been shown to carry
malignant potential and should be resected [39, 43].
3.2. Hamartomatous polyps
Hamartomatous polyps are polyps that may grossly resemble normal colonic tissue but are
histologically a mixture of tissues growing in disarray. Histologically, they contain mucous-
filled glands, retention cysts, abundant connective tissue, and/or chronic eosinophilic infiltra‐
Figure 6. Histologic representation of a tubulovillous adenoma in the background of normal colon tissue.
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Figure 7. Potential molecular pathways of serrated neoplasia.
Figure 8. A) Sessile serrated polyp with mucosal cap under white-light colonoscopy. (B) Sessile serrated polyp under NBI.
(C) Histology of sessile serrated polyp demonstrating expanded crypt proliferative zone, exaggerated architecture in crypt
region with basilar crypt dilation, inverted crypts, and a predominance of crypts with minimal cell maturation.
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tion [44]. Traditionally, they have been classified as non-neoplastic but several associated
polyposis syndromes (e.g., Juvenile Polyposis Coli, Peutz-Jegher Syndrome, Cronkhite
Canada Syndrome, and Cowden Syndrome) do carry a predilection towards colorectal cancer
and other gastrointestinal malignancies.
Juvenile polyps are a type of hamartomatous polyp characterized by dilated cystic glands
rather than an increased number of epithelial cells [44]. They can be found at any age, but as
the name implies, are more commonly diagnosed during childhood. They are typically
removed due to their propensity to bleed. Peutz-Jegher polyps are a type of hamartomatous
polyp characterized by glandular epithelium supported by smooth muscle cells contiguous
with the muscularis mucosa. Figure 9 depicts an endoscopic view of a hamartomatous polyp
and histologic view of a Peutz-Jegher polyp.
Figure 9. Endoscopic view of a hamartomatous polyp and histologic view of a Peutz-Jegher polyp.
3.3. Inflammatory pseudopolyps
Inflammatory polyps, typically seen in IBD, are indicative of regenerative and/or healing
phases of mucosal ulceration and possess no malignant potential. They are formed from
discrete islands of residual intact colonic mucosa that result from the ulceration and tissue
regeration that is inherent to the disease course [45]. Scattered throughout the colitic region of
the colon, they are often numerous, filiform, and can be large enough to encompass the lumen
resulting in intussusception or luminal obstruction [45, 46]. The clinical endoscopist ought to
be cognizant of clusters of localized giant pseudopolyposis as they may be associated with
occult dysplasia [47]. Histologically, inflammatory pseudopolyps are characterized by
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inflamed lamina propria and distorted colonic epithelium [48]. Surface erosions, congestion,
hemorrhage and/or crypt abscesses may also be present [48]. Figure 10 depicts an endoscopic
and histologic view of an inflammatory pseudopolyp.
Figure 10. Endoscopic and histologic view of an inflammatory pseudopolyp.
4. Colitis
4.1. Inflammatory bowel disease
In patients with a clinical presentation suggestive of IBD, colonoscopy with ileoscopy can be
used to make the initial diagnosis as it allows for direct visualization and biopsy of rectal,
colonic, and terminal ileum mucosa [49]. In addition, it can assess disease activity and monitor
therapeutic response, provide surveillance of dysplasia or neoplasia, and lastly provide
therapeutic intervention such as stricture dilation [49] or closure of fistulae and anastomotic
leakages [50].
The use of endoscopic appearance in distinguishing IBD from other non-IBD colitides is limited
[51] as there are a number of ‘IBD mimickers’ including but not limited to colonic tuberculosis
[52], Behçet's disease [53], and segmental colitis associated with diverticular disease [54]. In
addition to tuberculosis, there are hosts of other infectious colitides that can also endoscopi‐
cally mimic IBD [51, 55]. Table 1 provides an endoscopic description of various infectious
colitides. Once these other etiologies have been excluded, colonoscopy can often shed light in
distinguishing Crohn’s disease (CD) from ulcerative colitis (UC), which is important for
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disease management. The data gathered from an index colonoscopy is of utmost importance
owning to the fact that once therapy is initiated for IBD, discriminating features of CD from
UC may be obscured [56, 57].
Infectious Etiology Endoscopic Appearance
Apergillus Hemorrhagic ulcerations
Campylobacter Colonic erythema and ulceration
Chlamydia Perianal abscesses, ulcerations, and fistulae
C. difficile Pseudomembranes and moderately severe colitis,
predominantly left sided
Cytomegalovirus Colitis with ulceration (typically punched out and shallow)
Entamoeba Acute colitis with ulceration
E. coli 0157:H7 Moderately severe colitis
Herpes Proctitis with ulceration, there may be perianal
involvement as well.
Histoplasma Moderately severely colitis, predominantly right sided
Klebsiella Hemorrhagic colitis
Mycobacterium Ileal ulceration, may be transverse or circumferential
Nessieria Proctitis with ulceration, there may be perianal
involvement as well
Salmonella Friable mucosa, ileal and colonic hemorrhages often
present
Schistosoma Extensive colitis may be segmental, polyps often times
present
Shigella Intense patchy colonic erythema that can also include the
ileum
Treponema Proctitis with ulceration, there may be perianal
involvement as well
Yersinia Patchy colitis with ileal ulceration (apthoid)
Table 1. Endoscopic description of various infectious colitides [54].
4.1.1. Endoscopic features of UC and Mayo Scoring System
Endoscopically, classic UC starts in the rectum and progresses proximally, sometimes as far
as the ileo-cecal valve, in a circumferential and contiguous fashion with diffused and contin‐
uous inflammation [58]. Endoscopic features suggestive of UC include erythema, edema
resulting in a loss of the usual vascular patter, granular appearing mucosa, increased friability,
and small superficial erosions and ulcers surrounded by diffuse inflammation [59]. These
classic visual features are used to endoscopically score the extent of the disease. The Mayo
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Scoring System was derived in order provide an objective measure describing the endoscopic
extent of the disease. Lemmens et al. sought to evaluate the correlation between endoscsopy
and histology with use of the Mayo Scoring System [60]. This retrospective study included 236
biopsy sets from 131 patients with known UC. Endoscopy was performed by IBD specialists
and graded using the Mayo Scoring System. Biopsy specimens were analyzed by expert
gastrointestinal pathologists using the Geboes and Riley histologic scoring systems. They
found that at both extremes, inactive and severely active disease, there was a very high
concordance rate. For mild disease, however, there were important differences, as histologic
examination seemed to have detected more severe disease than endoscopically suspected, thus
stressing the need for a combined histologic and endoscopic scoring system when assessing
disease activity. Figure 11 depicts the classic endoscopic appearance of UC in relation to the
Mayo Scoring System.
Figure 11. Classic endoscopic appearance of UC in relation to the Mayo Scoring System.
4.1.2. Endoscopic features of CD and the Simple Endoscopic Score for CD (SES-CD)
Inflammation in CD can span the entire gastrointestinal tract with nearly 55% of cases
involving the terminal ileum and colon, 40% involving exclusively the ileum, and 25%
involving the colon alone [61]. Rectal involvement occurs in up to 50% of patients with CD [62].
It should be noted that while terminal ileal involvement is strongly suggestive of CD, it might
also occur in patients with UC, particularly pan-colitic UC, by way of “backwash” of cecal
contents or “backwash ileitis” [63, 64]. The exact pathogenesis of “backwash ileitis” remains
poorly understood, however it is believed that in patients with pan-colitic UC, the terminal
ileum becomes inflamed stemming from chronic exposure to cecal contents.
Endoscopically, classic CD appears as “skip lesions” or areas of inflammation interposed
between islands of normal mucosa, “cobblestone” appearance of the mucosal surface due to
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submucosal inflammation and edema, and deep, longitudinal, polycyclic ulcers [55]. In 2004,
the SES-CD was derived in order to provide an objective measure describing the endoscopic
extent of the disease [65]. To date, prospective data evaluating the utility of SES-CD in
predicting corticosteroid-free clinical remission and long-term disease progression is lacking
[66, 67]. Figure 12 depicts the classic endoscopic appearance of CD as well as the SES-CD. Table
2 illustrates the key endoscopic differences between UC and CD.
Figure 12. Classic endoscopic appearance of CD as well as the SES-CD.
Endoscopic Features Ulcerative Colitis Crohn’s Disease
Aphthous Ulcers √ √√√
Cobblestone Appearance x √√
Deep Ulcers x √√√
Erythema √√√ √√
Granular Mucosa √√√ √
Ileal Ulcers x √√√
Loss of Vascular Pattern √√√ √
Pseudopolyp √√√ √√√
Patchy Inflammation x √√√
Rectal Involvement √√√√ √√
Table 2. Key endoscopic differences between UC and CD [54].
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4.2. Microscopic (Lymphocytic and collagenous) and eosinophilic colitis
While microscopic colitis by definition is a histologic diagnosis, emerging data suggests that
it may not always present with normal endoscopic findings [68–72]. Microscopic colitis is
further subdivided into lymphocytic colitis and collagenous colitis depending on the presence
of lymphocytic predominant infiltration or collagen deposition, respectively [73]. There have
been several macroscopic lesions associated with collagenous colitis including longitudinal
ulcers [69,70], hypervascularity [71], loss of normal vascularity [72], and exudative bleeding
[73]. A retrospective study by Park et al. sought to investigate macroscopic lesions seen on the
endoscopy in 14 patients with diagnosed lymphocytic colitis [68]. Patients with more severe
diarrhea demonstrated macroscopic lesions on colonoscopy that included hypervascularity
and exudative bleeding, which led to the conclusion that lymphocytic colitis may not always
present with a normal endoscopically appearing mucosa. Figure 13 depicts lymphocytic colitis
associated with hypervascular mucosa and exudative bleeding.
Figure 13. Hypervascular mucosa and exudative bleeding associated with lymphocytic colitis.
Eosinophilic disorders can span the entirety of the gastrointestinal tract, including the
esophagus (eosinophilic esophagitis), stomach and small intestine (eosinophilic gastroenteri‐
tis), and the colon (eosinophilic colitis). Eosinophilic colitis is the least frequent manifestation
of primary eosinophilic gastrointestinal disorders with only a few reports reported over the
last four decades [74]. Secondary eosinophilic colitis can stem from several conditions
including parasitic infections (e.g., Strongyloides stercoralis [75], Enterobius vermicularis [76], and
Trichuris trichiura [77]), drug-induced (e.g., clozapine [78], carbamazepine [79], rifampicin [80],
non-steroidal anti-inflammatory drugs [81, 82], tacrolimius [83], and gold [84]), auto-immune
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disorders (e.g., scleroderma [85], dermatomyositis and polymyositis [86, 87], and vasculitides
(e.g., Churg-Strauss syndrome [88]). Endoscopic features suggestive of eosinophilic colitis
include an edematous mucosa with loss of normal vascular pattern, patchy erythema, and
superficial ulcerations [74].
4.3. Ischemic colitis
Ischemic colitis occurs as a result of inadequate blood supply to the large colon, typically
affecting the critically ill and elderly population [89]. A recent retrospective study by Church
et al. examined the role of urgent bedside colonoscopy in critically ill patients [90]. This study
included 41 patients totaling 49 bedside colonoscopies with the most common indication being
to exclude ischemic colitis (n=25). Of those 25, the diagnosis was confirmed in 19 with 14
patients subsequently undergoing surgical intervention, which led the authors to conclude
that bedside colonoscopy is helpful in the diagnosis of acute lower gastrointestinal disease and
can potentially guide therapeutic management in critically ill patients. There are several
endoscopic findings that may assist in the diagnosis of ischemic colitis, one of which is the
colon single-stripe sign. Zuckerman retrospectively studied 26 patients with endoscopic
evidence of the colon single-stripe sign and compared it with 58 consecutive patients without
a stripe [91]. All patients in the colon single-strip cohort had a stripe that was >5cm in length
predominantly in the left colon (89%). Patients with the colon single-stripe sign were signifi‐
cantly more likely to have evidence of a preceding ischemic event (62%) compared to the colitis
comparison group (7%). Histologically, patients with the colon single-stripe sign had micro‐
scopic evidence of ischemic injury compared to the colitis cohort (75% vs. 13%, respectively;
p<0.0001). Next, the clinical course and outcome of the 26 patients with the colon single-stripe
sign was compared with 22 patients with circumferentially involved ischemic colitis. None of
the patients with the colon single-stripe sign required surgical intervention compared with
27% of patients with circumferential ischemic colitis. In addition, mortality rates were higher
in the circumferential ischemic colitis group compared with patients with the colon single-
stripe sign (41% vs. 4%, respectively; p<0.05). This led the authors to conclude that the colon-
single stripe sign can manifest endoscopically, typically in a milder disease in the clinical
spectrum of ischemic colitis [91]. Other endoscopic manifestations of ischemic colitis include
petechial hemorrhages, edematous and fragile mucosa, segmental erythema, scattered
erosions, and longitudinal ulcerations [92]. The ‘watershed areas’ areas (e.g., splenic flexure
and transverse colon) are areas most vulnerable to ischemia due to the fact that they have the
fewest collateral circulation. Figure 14 depicts various endoscopic manifestations of ischemic
colitis.
4.4. Graft-Versus-Host Disease (GVHD)
Acute GVHD is associated with significant morbidity and mortality in the first 100 days
following allogeneic hematopoietic progenitor stem cell transplant [93]. Acute GVHD can have
GI manifestations (abdominal pain, nausea/vomiting, and diarrhea), obstructive jaundice, or
skin rash. Gastroenterologists are often times consulted for endoscopic evaluation to rule out
GHVD, when post-transplant patients present with GI manifestations in the absence of liver
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or dermatologic involvement. In a majority of patients, flexible sigmoidoscopy with rectal
biopsies allow for histologic diagnosis of GVHD and thus colonoscopy is not necessary [94,
95]. Endoscopic features of GVHD include diffuse edema, hyperemia, patchy erosions,
scattered ulcers, sloughing, and active bleeding [96].
5. Evaluation of Lower Gastrointestinal Bleeding (LGIB)
The incidence of LGIB is approximately 20 per 100,000, with an associated all cause mortality
of 3.9% [97].  The three most common causes of  LGIB include angioectasias,  diverticular
bleeding, and hemorrhoidal bleeding [98]. Colonic ulcerations secondary to underlying IBD
or  chronic  NSAID  use,  stercoral  ulcer,  Dieulafoy’s  lesion,  or  colorectal  varices  are  less
common etiologies of LGIB. In addition, an upper gastrointestinal source should also be
included in the differential being that upwards of 15% of patients with severe hematoche‐
zia are found to have an upper gastrointestinal source [99]. In a hemodynamically stable
patient, colonoscopy remains the cornerstone in the diagnosis of an LGIB. Figure 15 is a
suggested algorithm by Parekh et  al.  for  the role  of  colonoscopy in the evaluation of  a
hemodynamically stable LGIB [100].
Diverticulosis of the colon is an out-pouching of colonic mucosa through weakened layers of
muscle in the colon wall. The incidence of diverticular increases after the age of 40 [101]. While
in itself benign, complications of diverticular disease include diverticulitis, which is the
inflammation or infection of diverticula, and painless bleeding, which may be life threatening.
Figure 14. Various endoscopic manifestations of ischemic colitis.
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Therefore, it is important for the endoscopist to inform the patient of symptoms of potential
complications of diverticular disease.
Colonic angioectasias, previously referred to as arteriovenous malformations or angiodyspla‐
sias, are a common source of lower gastrointestinal bleeding [102]. They can often times be
difficult to identify if not actively bleeding. Figure 16 is an example of colonic diverticula and
an angioectasia seen endoscopically.
Figure 16. Colonic diverticula and an angioectasia seen endoscopically.
Figure 15. Suggested algorithm by Parekh et al. for the role of colonoscopy in the evaluation of a hemodynamically
stable LGIB [100].
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6. Hemorrhoids and anal fissures
Hemorrhoids are vascular structures in the anal canal that act as cushions to help with stool
control [103]. When they become swollen or inflamed, internal hemorrhoids (above the dentate
line) can present as painless rectal bleeding. External hemorrhoids can result in pain when
thrombosed, or painful bleeding if ulceration occurs from pressure necrosis [103]. Skin tags
may be evidence of prior thrombosed external hemorrhoids.
An anal fissure is a linear tear or crack in the distal anal canal. It often presents as painful
defecation. Initially it usually involves only the epithelium and progresses to include the full
thickness of the anal mucosa. Figure 17 is an example of an internal hemorrhoid, external
hemorrhoid, skin tag, and an anal fissure.
Figure 17. Internal hemorrhoid, external hemorrhoid, skin tag, and an anal fissure.
7. Conclusion
Colonoscopy is important in the diagnosis and therapeutic management of several disease
states. To date, colonoscopy remains the gold standard in colorectal cancer prevention. It is
the cornerstone in the diagnosis and therapeutic management of IBD, particularly with the
recent paradigm shift in the therapeutic management of IBD stressing the importance of
endoscopic remission in addition to symptomatic remission. In addition, a thorough colono‐
scopic exam can aid in the diagnosis of other non-IBD colitides. In the acute setting, findings
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during colonoscopy are not only crucial in diagnosing the underlying etiology but also driving
therapeutic management. As technology evolves and indications for colonoscopy expand, it
becomes increasingly more crucial for the clinical endoscopist to be knowledgeable of normal
and pathologic findings during colonoscopy.
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